Global menu

Our global pages

Close
 
Tony McGovern, Partner

Tony McGovern

Partner

Practice areas

  • Commercial and IT
  • Corporate
  • Intellectual property
  • Life sciences
  • Mergers and acquisitions
  • Technology

Practice notes

Tony is a partner for corporate and commercial, in the Dublin office.

"cuts straight to the chase. He can understand the issue, focus on the commercial elements and provide solid, practical advice in a technical environment" - Chambers Europe 2014

“He is more approachable than most lawyers I deal with. He is balanced and will always present the issues in the right context.”  - Chambers Europe 2012
 
"good at navigating the transaction to a successful conclusion" - Legal 500 2011
 
With more than twenty years of practice in the area Tony is a highly regarded lawyer with a wealth of experience in the Corporate sector. His experience of providing advice to the technology sector in Ireland has seen him involved in some of the most high profile and complex transactions in the sector.
 
Tony's recent experience includes:
  • Advising Vivasure Medical on its Series C funding round from a group of international VC’s together with its existing investor group;
  • Advising Integumen Group in connection with the acquisition of the business and assets of Enhance Skin Products Inc.
  • Advising Venn Life Sciences Holdings PLC on the acquisition of Kenesis Pharma.
  • Leading the team in the disposal of Risk Intelligence Ireland Limited to Verisk Analytics .
  • Advising on the acquisition of Maydown Precision Engineering by Schivo Group.
  • Leading the Eversheds team in the disposal of System Dynamics Group to Deloitte.
  • Advising the majority shareholder of Klas Telecom Group on the Buy In and Management Buy Out of the original founders.
In addition he brings a strong commercial attitude to the business of exploiting knowledge assets for a diverse range of technology clients across sectors such as ICT, Medical Devices and Pharma.

undefined   undefined

Related news

Title Date
Derivative actions and what it entails02/06/2017